Seppic, an Air Liquide Healthcare company, which develops, produces and distributes a wide range of specialty ingredients for health and beauty, announces the implementation of its first production facility in the United States. This is Seppic’s second largest facility for the production of high performance specialty ingredients used for the cosmetic and pharmaceutical markets.
The new facility, which is already in operation, provides Seppic with more than 50 percent additional production capacity for thickeners and texturizers to meet the growing demands of its customers in the United States and around the world.
Located near Richmond, Virginia, the site was strategically selected for its skilled workforce and will boost the local community by creating more than 50 jobs. The site is also ideally located to serve the northeastern United States, where 80 percent of Seppic’s U.S. customers are located, and the export market.
The facility has been designed to meet the highest levels of quality in accordance with Good Manufacturing Practice (GMP), and has already achieved ISO 9001, EFfCI and RSPO certification. The facility currently operates fully automated units to enable consistent and easily traceable quality of ingredients. With this state-of-the-art technology and the recycling of 95% of its waste, Seppic minimises its impact on the environment.
Specialty ingredients for cosmetics represent a market of more than 10 billion dollars worldwide, 25% of which is in the United States.
“With this new facility, we are increasing our industrial capacity to serve our customers worldwide,” commented Jean-Baptiste Dellon, Seppic’s CEO. “This state-of-the-art facility is in compliance …
